NsGene
closedNsGene develops products for the treatment of neurological, alzheimer’s, and parkinson's disease and sensorineural hearing loss.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor investor investor investor | €0.0 | round | |
| N/A | $550k | Grant | |
| Total Funding | 000k | ||
| DKK | 2013 | 2014 | 2015 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | (22 %) | 31 % |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| % profit margin | 41 % | 92 % | 97 % |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.